Find a Cancer Provider

Are you a referring physician?
within
I am searching for a
Reset Form
Ashley F. Haggerty, MD, MSCE

Ashley F. Haggerty, MD, MSCE Physician

Chair, Gynecology Quality Improvement Committee Physician Lead, Women's Health Unit Based Leadership Council Silverstein 7 Assistant Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania

Dr. Haggerty is employed by Penn Medicine.

Clinical Specialties

Specialty:

  • Gynecologic Oncology

Programs & Centers:

Board Certification:

  • Obstetrics and Gynecology - Gynecologic Oncology, 2017
  • Obstetrics and Gynecology, 2014

Clinical Expertise:

  • Cervical Cancer
  • Cervical Dysplasia
  • Cervical Lesions
  • Cervix Biopsy
  • Chemotherapy for Gynecologic Cancers
  • Colposcopy
  • Endometrial Cancer
  • Fallopian Tube Cancer
  • Gynecologic Cancer
  • Gynecologic Cancer Surgery
  • Gynecologic Surgery
  • Gynecology Clinical Trials
  • Hysterectomy (Uterus Surgery)
  • Hysteroscopy
  • Laparoscopic Hysterectomy
  • Laparoscopic Supracervical Hysterectomy
  • Laparoscopic Surgery
  • Laparoscopy
  • Loop Electrosurgical Excision Procedure (LEEP)
  • Minimally Invasive Hysterectomy
  • Ovarian Cancer
  • Robotic Surgery
  • Trophoblastic Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Vulvar Cancer

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Wake Forest University
Residency: Hospital of the University of Pennsylvania
Fellowship: Hospital of the University of Pennsylvania

Memberships

American Congress of Obstetricians and Gynecologist, National American Society of Clinical Oncology, National Society of Gynecologic Oncology, National

Hospital Affiliation

Dr. Haggerty is employed by Penn Medicine.

Hospital Privileges:

  • Chester County Hospital: Has privileges to treat patients in the hospital.
  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Buckingham L, Haggerty A, Graul A, Morgan M, Burger R, Ko E, Andy U, Giuntoli R2.: Sexual function following hysterectomy for endometrial cancer: A five-year follow up investigation. Gynecol Oncol. : 152(1):139-144. ,2019.

Nasioudis D; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Ko EM; Latif NA.:: Does chemotherapy improve survival of patients with stage II high-grade endometrioid carcinoma of the uterus.Poster presentation at the Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan. (Abstract) : 2018.

Nasioudis D; Mastroyannis SA; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Ko EM; Latif NA.:: Presence of lymph-vascular invasion is associated with a worse prognosis for patients with advanced stage malignant ovarian germ cell tumors. Poster presentation at the Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan. (Abstract) : 2018.

Nasioudis D; Kanninen T; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Ko EM; Latif NA.:: Residual disease is associated with a worse prognosis in patients with advanced stage sex cord-stromal tumors. Poster presentation at the Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan. (Abstract) : 2018.

Nasioudis D; Mastroyannis SA; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Ko EM; Latif NA.:: Trends in the surgical management of malignant ovarian germ-cell tumors. Poster presentation at the Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan. (Abstract) : 2018.

Nasioudis D; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Ko EM; Latif NA.:: Minimally invasive staging for stage I type II uterine cancer: use and outcomes. Poster presentation at the Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan. (Abstract) : 2018.

Nasioudis D; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Ko EM; Latif NA.:: Type of treatment facility impacts survival of patients with ovarian clear cell carcinoma. Poster presentation at the Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan. (Abstract) : 2018.

Nasioudis D; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Ko EM; Latif NA.:: Does surgical approach influence the rate of positive peritoneal cytology and lymph-vascular invasion for patients with stage I uterine cancer. Poster presentation at the Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan. (Abstract) : 2018.

Graul A, Wilson E, Ko E, Haggerty AF, Reed H, Koelper N, Kim SH.: Conservative management of endometrial hyperplasia or carcinoma with the levonorgestrel intrauterine system may be less effective in morbidly obese patients. Gynecol Oncol Rep. : 12;26:45-48,2018.

Nasioudis D; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Ko EM; Latif NA.:: Is adjuvant chemotherapy associated with a survival benefit for patients with stage I mucinous ovarian carcinoma?" Oral presentation at the Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan. (Abstract) : 2018.

Academic Contact Info

Jordon Center for Gynecologic Cancer
3400 Civic Center Blvd, 3 West
Perelman Center for Advanced Medicine

Philadelphia, PA 19104
Phone: (215) 662-3318
Patient appointments: 800-789-7366 (PENN)